These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12528528)

  • 1. [Study of deletion and mutation of p16 gene in primary hepatocellular carcinoma].
    Qin Y; Chen J; Li B; Sun Z; Zuo F; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):492-4, 500. PubMed ID: 12528528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutation analysis of the p15 gene exon 2 in human primary hepatocarcinoma].
    Qin Y; Li B; Tan Y; Sun Z; Sun Z; Zuo F
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):360-3. PubMed ID: 10743227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the inactivation of p16 genes and the expression of P16 protein in primary hepatocellular carcinomas].
    Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):306-9. PubMed ID: 12545816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [p16 and cyclinD1 protein expression and p16 gene mutation in primary human hepatocellular carcinoma].
    Huang GX; Cheng RX; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):527-30. PubMed ID: 12536530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
    Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
    Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of p16 gene on carcinogenesis of hepatitis B virus related hepatocellular carcinoma].
    Wang ZW; Peng ZH; Li K; Qiu GQ; Zhang Y; Gu W
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):356-8. PubMed ID: 12921565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
    Su C; Ye Y; Wang D; Cao X; Li S; Shan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):37-40. PubMed ID: 11836684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
    Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
    Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN; Zha XL; Yu Q; He JY
    Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
    Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
    Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
    Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
    Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma].
    Zhang J; Wang K; Cong S; Qiu F; Wang X; Wang P
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):294-6. PubMed ID: 11676877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma.
    Tsai CH; Yang CC; Chou LS; Chou MY
    J Oral Pathol Med; 2001 Oct; 30(9):527-31. PubMed ID: 11555154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
    Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of the p16-Rb pathway in Korean hepatocellular carcinomas.
    Lee TJ; Bae JJ; Lee JS; Lee SY; Kim HJ; Kim SK; Lee JY; Lee TY
    Hepatogastroenterology; 2000; 47(36):1663-8. PubMed ID: 11149028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of p16 and p15 genes in human uterine tumours.
    Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
    Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.